Interestingly, two additional dysmorphic Gorlin patients in our cohort – one harboring a PTCH1 and the other a SUFU mutation - presented with developmental delay prior to the diagnosis of the medulloblastoma/the beginning of treatment. The gene discussed is PTCH1; the disease is medulloblastoma.